About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Zahar, Jean Ralph ^a,b   Poirel, Laurent ^c,d   Dupont, Claire ^c   Fortineau, Nicolas ^c   Nassif, Xavier ^b   Nordmann, Patrice ^c,d,e  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICÊTRE HOSPITAL   (France)

^d University of Fribourg   (Switzerland)

^e Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

Hand hygiene; Infection control; Isolation; lactamase

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; COMPARATIVE STUDY; CONTACT PRECAUTION; DRUG USE; EPIDEMIC; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FRANCE; HAND WASHING; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; ANTIBIOTIC RESISTANCE; CROSS INFECTION; ENTEROBACTERIACEAE; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HETEROZYGOTE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION;

BETA LACTAMASE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER STATE; CHILD; CROSS INFECTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; PARIS; RETROSPECTIVE STUDIES;

EID: 84946842250     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1244-x     Document Type: Article

References (26)

1. Zahar JR, Lortholary O, Martin C, Potel G, Plésiat P, Nordmann P. Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Investig Drugs. 2009;10:172-80.
2. Chen YH, Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect. 2011;62:280-91.
3. Gibold L, Robin F, Tan RN, Delmas J, Bonnet R. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital. Clin Microbiol Infect. 2014;20:O20-6.
4. Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect. 2011;17:557-65.
5. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum ß-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2009;63:1135-41.
6. Hebert C, Weber SG. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA). Infect Dis Clin North Am. 2011;25:181-200.
7. Lucet JC, Decré D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, et al. Control of a prolonged outbreak of extended-spectrum ß-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29:1411-8.
8. Mendonca N, Leitao J, Manageiro V, Ferreira E, Canica M. Spread of extended-spectrum ß-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother. 2007;51:1946-55.
9. Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19:141-60.
10. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, et al. Trends in production of extended-spectrum ß-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother. 2011;66:37-47.
11. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010;170:552-9.
12. Aumeran C, Baud O, Lesens O, Delmas J, Souweine B, Traoré O. Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France. Eur J Clin Microbiol Infect Dis. 2008;27:1061-4.
13. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet. 2005;365:295-304.
14. Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, et al. Community faecal carriage of extended-spectrum ß-lactamase-producing Enterobacteriaceae in French children. BMC Infect Dis. 2012;12:315.
15. Kirkland KB. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis. 2009;48:766-71.
16. Kaier K, Frank U, Hagist C, Conrad A, Meyer E. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum ß-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother. 2009;63:609-14.
17. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum ß-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45:846-52.
18. Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Batlle M, et al. Risk factors for, and clinical relevance of faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30:355-60.
19. Chang S, Sethi AK, Eckstein BC, Stiefel U, Cadnum JL, Donskey CJ. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillance. Clin Infect Dis. 2009;48:1423-8.
20. Goddard S, Muller MP. The efficacy of infection control interventions in reducing the incidence of extended-spectrum ß-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: A systematic review. Am J Infect Control. 2011;39;599-601.
21. Giuffre M, Cipolla D, Bonura C, Geraci DM, Aleo A, Di Noto S, et al. Outbreak of colonizations by extended-spectrum ß-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit. Italy Antimicrob Resist Infect Control. 2013;2:8.
22. Willemsen I, Nelson J, Hendriks Y, Mulders A, Verhoeff S, Mulder P, et al. Extensive dissemination of extended spectrum ß-lactamase-producing Enterobacteriaceae in a Dutch nursing home. Infect Control Hosp Epidemiol. 2015;36:394-400.
23. Oteo J, Cercenado E, Fernandez-Romero S, Saez D, Padilla B, Zamora E, et al. Extended-spectrum ß-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain. Antimicrob Agents Chemother. 2012;56:54-8.
24. Karami N, Helldal L, Welinder-Olsson C, Ahren C, Moore ER. Sub-typing of extended-spectrum ß-lactamase-producing isolates from a nosocomial outbreak: application of a 10-loci generic Escherichia coli multi-locus variable number tandem repeat analysis. PloS One. 2013;8:e83030.
25. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum ß-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55:1505-11.
26. Nordmann P, Dortet L, Poirel L. Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2012;50:3016-22.